111 related articles for article (PubMed ID: 7966129)
1. Synthesis and diuretic activity of alkyl- and arylguanidine analogs of N,N'-dicyclohexyl-4-morpholinecarboxamidine in rats and dogs.
Perricone SC; Humphrey SJ; Skaletzky LL; Graham BE; Zandt RA; Zins GR
J Med Chem; 1994 Oct; 37(22):3693-700. PubMed ID: 7966129
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of the K-ATP channel blocker U-37883A and structurally related morpholinoguanidines.
Humphrey SJ; Smith MP; Cimini MG; Buchanan LV; Gibson JK; Khan SA; Meisheri KD
Methods Find Exp Clin Pharmacol; 1996 May; 18(4):247-60. PubMed ID: 8803957
[TBL] [Abstract][Full Text] [Related]
3. Diuretic activity of N'-disubstituted morpholinoguanidine analogs of U-37883A in rats and dogs.
Humphrey SJ; Ludens JH; Perricone SC; Skaletzky LL; Graham BE; Zins GR
Methods Find Exp Clin Pharmacol; 1995 May; 17(4):255-66. PubMed ID: 7475512
[TBL] [Abstract][Full Text] [Related]
4. 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.
Meisheri KD; Humphrey SJ; Khan SA; Cipkus-Dubray LA; Smith MP; Jones AW
J Pharmacol Exp Ther; 1993 Aug; 266(2):655-65. PubMed ID: 8355199
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the diuretics torasemide and U-37883A with the K(ATP) channel in rat isolated aorta.
Löffler-Walz C; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):230-7. PubMed ID: 9750009
[TBL] [Abstract][Full Text] [Related]
6. Guanidine derivative U-37883A, inhibits mitochondrial K+ uniport.
Szewczyk A; Wójcik G; Jabłonowska A; Nałecz
Pol J Pharmacol; 1995; 47(4):339-44. PubMed ID: 8616514
[TBL] [Abstract][Full Text] [Related]
7. K-ATP-blocking diuretic PNU-37883A reduces plasma renin activity in dogs.
Humphrey SJ; Ludens JH
J Cardiovasc Pharmacol; 1998 Jun; 31(6):894-903. PubMed ID: 9641474
[TBL] [Abstract][Full Text] [Related]
8. Effects of K-ATP blocking guanidine diuretics during experimental kaliuresis in rats and dogs.
Humphrey SJ
Methods Find Exp Clin Pharmacol; 1995 Oct; 17(8):519-28. PubMed ID: 8749224
[TBL] [Abstract][Full Text] [Related]
9. Selective in vivo antagonism of pinacidil-induced hypotension by the guanidine U37883A in anesthetized rats.
Smith MP; Humphrey SJ; Jackson WF
Pharmacology; 1994 Dec; 49(6):363-75. PubMed ID: 7878074
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Profile of U-37883A, a Channel Blocker of Smooth Muscle-Type ATP-Sensitive K Channels.
Teramoto N
Cardiovasc Drug Rev; 2006; 24(1):25-32. PubMed ID: 16939631
[TBL] [Abstract][Full Text] [Related]
11. The natriuretic activity of the K+ channel blocker U-37883A displays an ADH-dependence.
Clark MA; Lawson JA; Ludens JH
Methods Find Exp Clin Pharmacol; 1998 Mar; 20(2):115-23. PubMed ID: 9604853
[TBL] [Abstract][Full Text] [Related]
12. Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.
Meisheri K; Fosset M; Humphrey S; Lazdunski M
Mol Pharmacol; 1995 Jan; 47(1):155-63. PubMed ID: 7838124
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
Ohrnberger CE; Khan SA; Meisheri KD
J Pharmacol Exp Ther; 1993 Oct; 267(1):25-30. PubMed ID: 8229751
[TBL] [Abstract][Full Text] [Related]
14. Effects of a K+ channel blocker on glomerular filtration rate and electrolyte excretion in conscious rats.
Ludens JH; Clark MA; Lawson JA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1375-81. PubMed ID: 7791110
[TBL] [Abstract][Full Text] [Related]
15. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
Guillemare E; Honore E; De Weille J; Fosset M; Lazdunski M; Meisheri K
Mol Pharmacol; 1994 Jul; 46(1):139-45. PubMed ID: 8058048
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.
Wellman GC; Barrett-Jolley R; Köppel H; Everitt D; Quayle JM
Br J Pharmacol; 1999 Oct; 128(4):909-16. PubMed ID: 10556925
[TBL] [Abstract][Full Text] [Related]
17. Effects of a novel KATP channel blocker on renal tubule function and K channel activity.
Wang T; Wang WH; Klein-Robbenhaar G; Giebisch G
J Pharmacol Exp Ther; 1995 Jun; 273(3):1382-9. PubMed ID: 7791111
[TBL] [Abstract][Full Text] [Related]
18. Eukaliuric diuresis and natriuresis in response to the KATP channel blocker U37883A: micropuncture studies on the tubular site of action.
Huang DY; Osswald H; Vallon V
Br J Pharmacol; 1999 Aug; 127(8):1811-8. PubMed ID: 10482911
[TBL] [Abstract][Full Text] [Related]
19. U-37883A potently inhibits dopamine-modulated K+ channels on rat striatal neurons.
Lin YJ; Chen X; Freedman JE
Eur J Pharmacol; 1998 Jul; 352(2-3):335-41. PubMed ID: 9716371
[TBL] [Abstract][Full Text] [Related]
20. Characterization of ATP-sensitive potassium channel-blocking activity of ZENECA ZM181,037, a eukalemic diuretic.
Kau ST; Zografos P; Do ML; Halterman TJ; McConville MW; Yochim CL; Trivedi S; Howe BB; Li JH
Pharmacology; 1994 Oct; 49(4):238-48. PubMed ID: 7831387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
